Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Peptide Proteomic Core Facility Opens

NEW YORK (GenomeWeb News) – The Brain Research Centre in Vancouver, Canada, earlier this month opened a new proteomic core facility.
The 50,000-square-foot Peptide Proteomic Core Facility, which opened Sept. 1, offers custom peptide synthesis along with peptide array services.
The BRC is a partnership between Vancouver Coastal Health hospital and the faculty of medicine at the University of British Columbia. It will offer services to enable the use of proteomic platforms for those on its campus and outside, the center said in a statement.
The peptide array platforms include epitope mapping, peptide library screening, and peptide substitution screening assays. Equipment at the new center includes analytical HPLCs, mass spectrometers, and autospotters, the center said.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.